PLMJ | Portugal | 12 Feb 2024
Ministerial Order 39-C/2024 of 2 February was published in order to define the reference countries to be taken into account in 2024 and the…
In-Depth
PRO
Editor:
Peter Bogaert
Covington & Burling LLP
In-Depth: Life Sciences Law (formerly The Life Sciences Law Review) is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology and medical device companies in key jurisdictions worldwide. It covers the major rules and restrictions throughout the life cycle of regulated products, from discovery to clinical trials, the marketing authorisation process and post-approval controls. It also examines the most consequential recent trends and developments in the sector.
DLA Piper | Portugal | 8 Jan 2024
Since 2006, when the Medicines Code was approved in Portugal, marketing authorisation holders had to include the retail selling price of medicines on…
PLMJ | Portugal | 5 Jan 2024
Decree-Law 128/2023 was published on 26 December and introduces significant changes to information on the price of medicines. Among other things, the…
VdA | Portugal | 11 Oct 2023
Ao nível das contribuições setoriais, a Proposta do OE está em consonância com as escolhas feitas Nos últimos anos. Por um lado, opta-se por manter…
PLMJ | Portugal | 28 Aug 2023
Ministerial Order 264/2023 of 17 August was published to establish the operating model for the Autumn-Winter 2023-2024 Seasonal Vaccination Campaign…